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Abstract: Maternal diet during gestation and lactation affects the development of skeletal muscles
in offspring and determines muscle health in later life. In this paper, we describe the association
between maternal low protein diet-induced changes in offspring skeletal muscle and the differential
expression (DE) of small non-coding RNAs (sncRNAs). We used a mouse model of maternal protein
restriction, where dams were fed either a normal (N, 20%) or a low protein (L, 8%) diet during
gestation and newborns were cross-fostered to N or L lactating dams, resulting in the generation of
NN, NL and LN offspring groups. Total body and tibialis anterior (TA) weights were decreased in
weanling NL male offspring but were not different in the LN group, as compared to NN. However,
histological evaluation of TA muscle revealed reduced muscle fibre size in both groups at weaning.
Small RNA-sequencing demonstrated DE of multiple miRs, snoRNAs and snRNAs. Bioinformatic
analyses of miRs-15a, -34a, -122 and -199a, in combination with known myomiRs, confirmed their
implication in key muscle-specific biological processes. This is the first comprehensive report for the
DE of sncRNAs in nutrition-associated programming of skeletal muscle development, highlighting
the need for further research to unravel the detailed molecular mechanisms.
Keywords: maternal protein restriction; muscle development; offspring; microRNAs; sncRNAs;
snoRNAs
1. Introduction
Intrauterine growth restriction and low birthweight are linked with a predisposition
to adverse health consequences in adulthood, including insulin resistance, cardiovascular
disease, hypertension and obesity [1]. Therefore, the concept of foetal and perinatal
programming of later disease has been developed. Maternal diet during gestation and
lactation plays a crucial role in embryonic and post-natal development of the offspring
as it is the only source of nutrients through the placenta in pregnancy and provides all
essential components for neonatal growth during lactation. Poor maternal nutrition during
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gestation and/or lactation is known to reduce growth and impair muscle development and
stem cell activity [2–4], increase fat accretion [5] and alter metabolism [6] in the offspring.
Offspring skeletal muscle development is susceptible to maternal nutrient restriction which
also results in reduced offspring birth weight caused by decreases in foetal circulating
amino acids [7,8]. Studies using ovine foetuses and offspring exposed to a poor nutritional
environment in utero highlighted deficient muscle growth due to altered myofibre number
and composition [9,10]. Further studies using mouse and rat models of maternal protein
restriction suggested that this effect on muscle function may be long-lasting throughout the
life-course [11–13]. There is also evidence from human studies of low muscle fibre score
in elderly men born with low birth weight [14]. However, there is little understanding of
the cellular and molecular mechanisms whereby environmental modulation in utero or in
early postnatal life may lead to altered development of the musculoskeletal system [15,16].
The epigenetic regulation of skeletal muscle development and ageing has gained
significant interest during the last decade [17,18]. Small non-coding RNAs (sncRNAs)
are a class of epigenetic molecules including microRNAs (miRs), small nucleolar RNAs
(snoRNAs) and small nuclear RNAs (snRNAs). These RNA molecules are fully functional,
transcribed from DNA without processing for translation into proteins and, thus, act as
crucial factors regulating gene expression. All three types of sncRNAs have been implicated
in myogenesis and skeletal muscle development and regeneration [19,20]. miRs are non-
coding RNAs (ncRNAs), 19–22 nucleotides (nt) in length, that regulate post-transcriptional
gene expression and are linked to muscle development, disease and ageing [21,22]. Dietary
interventions result in changes in miR expression in muscle [23], suggesting that the effects
of diet on muscle may be mediated by miR-regulated changes in gene expression. miRs can
simultaneously regulate many genes and signalling pathways, and therefore potentially
physiological and pathological processes. It has been suggested that not all miRs are
ubiquitously expressed, but many miRs are expressed in a tissue-specific manner [24,25].
There is a class of miRs in which their expression is directly associated with striated muscle,
known as myomiRs [26], including miR-1, miR-133a, miR-133b, miR-206, miR-208b, miR-
486 and miR-499 [27–30]. Although myomiRs have been extensively studied, other miRs
may also be involved in regulating skeletal muscle development.
Ribosomes are considered as the cellular converters of the genetic codes, embedded
in messenger RNAs, converting these codes into proteins [31]. It is known that ribosomal
RNAs (rRNA) are post-transcriptionally modified via 2′O-ribose methylation or pseu-
douridylation [32]. These site-specific covalent modifications regulate the translational
process. snoRNAs are mainly intron-derived, 50–250 nt long ncRNAs with high expression
levels accumulating in the nucleolus. They are classified as C/D box snoRNAs (SNORDs),
which are responsible for 2′-O-methylation of rRNAs, or H/ACA box snoRNAs (SNORAs),
which guide pseudouridylation of nucleotides [33,34]. However, approximately half of
human snoRNAs have no predictable rRNA targets, and numerous snoRNAs have been
associated with diseases [35,36] that show no defects in rRNAs [37]. On the other hand,
snRNAs have an average size of 150 nt, which localise in the nucleus and mainly control
intron splicing [38]. snRNAs are present as ribonucleoprotein particles (snRNPs) forming
a large complex (spliceosome) which mediate splicing by attachment to the unspliced
primary RNA transcripts [39–41]. Despite the vital roles described, very little is known for
the specific functions of snoRNAs and snRNAs in skeletal muscle physiology.
In this study, we aimed to identify miRs, snoRNAs and snRNAs that may regulate
reduced skeletal muscle growth in the offspring due to maternal protein undernutrition
during pregnancy or during lactation. We utilised a mouse model of maternal protein
restriction and analysed small RNA-seq data derived from skeletal muscle of 21 days (21d)
male offspring to determine sncRNAs that are differentially expressed at weaning. Further-
more, we validated some of the observed differentially expressed (DE) miRs by qPCR and
performed an in silico bioinformatic analysis to unravel which signalling pathways and
cellular functions may be affected by these miRs.
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2. Materials and Methods
2.1. Animals
B6.Cg-Tg(Thy1-YFP)16Jrs/J mice, expressing yellow fluorescent protein (YFP) only in
neuronal cells (Jackson Laboratory; stock number 003709), were used in this study. Mice
were housed in individually vented cages maintained at 21 ± 2 ◦C on a 12 h light/dark
cycle. All experimental protocols were performed according to the UK Animals (Scientific
Procedures) Act 1986 regulations and obtained ethical approval from the University of
Liverpool Animal Welfare Ethical Review Board (AWERB). Animal use followed the 3Rs
guidelines. Mice were kept at the Biomedical Services Unit (BSU) of the University of
Liverpool and monitored daily for any health and welfare issues.
2.2. Experimental Groups
Mice were fed ad libitum with solid food pellets containing normal protein proportion
(N, 20% crude protein; Special Diet Services, UK; code 824226) or low protein proportion
(L, 8% crude protein; Special Diet Services, UK; code 824248) with isocaloric value. Eight-
week-old nulliparous female mice were fed on either N or L protein diet for two weeks
before mating with age-matched males on N diet. The pregnant mice were kept on the same
diet throughout gestation (19–21 days). Within 24 h after birth, male pups from N dams
were cross-fostered with other N dams (NN group, n = 5) or L dams (NL group, n = 5) that
were maintained under the same experimental conditions, but fed with L diet two weeks
prior to mating and during gestation and lactation (21 days), whilst pups from L dams
were transferred to N dams for lactation (LN, n = 5). Suckling pup numbers were kept the
same for all dams during the 21d lactation period (n = 5 pups) to avoid confounding issues
of litter size difference (Figure 1A). Male offspring were culled at the end of lactation by
CO2 euthanasia and weighed and tibialis anterior (TA) skeletal muscles were immediately
dissected and weighed.
Figure 1. Experimental design and skeletal muscle morphology. Illustrative description of the experimental design of the
study (A). Male 21d offspring lactated by dams on low protein diet (NL) were smaller in size (B) and had lower total body
(C) and TA muscle/body weight index (D) compared to the NN group, while offspring lactated by dams on normal protein
diet (LN) did not differ from NN control group. Histological assessment revealed that TA myofibre size was decreased
in both NL and LN groups, as shown in representative images (E) and measurements of muscle fibre minimum Feret’s
diameter (MFD) (F). All data are presented as mean ± SD. * p < 0.05, *** p < 0.001, ns, non significant. Scale bar: 100 µm.
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2.3. Skeletal Muscle Histology
To characterise the skeletal muscle phenotype, TA muscles (n = 4/group) were
mounted directly on a cork disk surrounded with Cryomatrix (Thermo ScientificTM, UK),
immersed in liquid nitrogen-frozen isopentane (Sigma Aldrich, UK) for cryoprotection and
stored at−80 ◦C until cryosectioning. TA muscles were placed at−20 ◦C for at least 30 min
prior to cryosectioning. Transverse sections (10 µm) were cut using a Leica cryotome and
collected on Superfrost glass slides (Thermo ScientificTM, UK). Sections were washed with
PBS for 10 min before staining with 1:1000 dilution of rhodamine wheat germ agglutinin
(WGA; 5 µg/mL; Vector Laboratories, UK) for 10 min, mounted in antifade medium (Vector
Laboratories, UK) and were visualised with an Axio Scan.Z1 slide scanner (Zeiss, UK).
Minimum Feret’s diameter (MFD) was measured using ImageJ software (U.S. National
Institutes of Health, USA).
2.4. RNA Isolation, Library Preparation for Small RNA-Seq and Sequencing
TA skeletal muscles were ground using a mortar and pestle and liquid nitrogen. Total
RNA was isolated and purified by the mirVanaTM kit (Thermo ScientificTM, UK) using
the manufacturer’s protocols. Samples were processed with Clip-ClapTM Acid Pyrophos-
phatase (Cambio, UK) prior to the library preparation to remove any 5′ cap structures, and
size selected using a range 120–300 bp including adapters ensuring the unbiased identifica-
tion of sncRNAs. Preparation of a small RNA-Seq library from submitted total RNA sample
was performed using the NEBNext® small RNA library preparation kit (New England Bio-
labs, UK). Small-RNA sequencing was conducted using the Illumina HiSeq 4000 (Illumina,
San Diego, CA, USA) at 2× 150-base pair (bp) paired-end sequencing, generating data from
>280 M clusters per lane. Sequencing was performed at the Centre for Genomic Research,
University of Liverpool (https://www.liverpool.ac.uk/genomic-research/, accessed on 9
May 2021).
2.5. Small RNA-Seq Data Processing
Mouse (mmu) mature miR sequences were downloaded from miRBase (v22.1) [42] in
FASTA format. For the alignment of sRNA reads, the FASTA format miRBase sequence files
were made non-redundant using java code and Uracil bases (U) were changed to thymine
(T). Small RNA reads were converted from FASTQ to FASTA format and then processed
to trim sequencing adaptors using the Perl script “Remove adaptors” [43], recognising
the first 8 bases of the adapter sequence. The processed reads were then aligned to the
processed mature miR sequences allowing zero mismatches using PatMaN [44] (parameters:
-s -e 0 -g 0 and -s -e 1 -g 0). Custom java code was used to parse the alignment files and
generate an aligned read count table across all samples. The DESeq2 [45] method within
iDEP [46] (version 91) was used for normalisation of counts between samples and calling
differentially expressed (DE) miRs using default settings.
To obtain sncRNA reference sequences, the Mus musculus (Genome Assembly GRCm38)
annotation in gff3 format was downloaded from Ensemble [47] (release-96) from which
all records representing a non-coding RNA gene with a snoRNA biotype were extracted
and converted into bed format. The processed annotation file in bed format along with the
Mus musculus genome top level assembly (Ensemble release-96, GRCm38) was used with
the function “getfasta” within the bedtools software [48] (parameters: -s -name) to extract
snoRNA sequences in FASTA format. The FASTA format snoRNA sequence file was then
made non-redundant using java code. The processed sRNA reads were then aligned to the
snoRNA sequences, aligned read count tables were generated and differential expression
analysis was performed as described above. Java code used for sequencing processing
along with count matrices are available online at https://github.com/lf-bioinformatics/
sRNA-code, accessed on 9 May 2021.
Data were assessed using pairwise comparisons, while correlation heatmaps and
principal component analysis (PCA) plots were visualised using the Clustvis web tool [49].
DE miRs were extracted by applying the threshold of false discovery rate (FDR) adjusted
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p-values < 0.05 (FDR < 0.05), generated using the Benjamini–Hochberg method [50] and
an absolute value of log2 fold change of 1.0 (|log2FC| > 1, equating to a 2-fold change)
in the first instance; thresholds of FDR < 0.001 and |log2FC| > 1.3 (equating to a 2.5-fold
change) and FDR < 0.05 and |log2FC| > 1.3 were applied when narrowing the DE miR
and snoRNAs ranges, respectively.
2.6. Quantitative Polymerase Chain Reaction (qPCR)
For miR expression analysis, total RNA was isolated and purified using the mir-
VanaTM kit (Thermo Fischer, UK), reverse transcription of total RNA containing miRs was
performed with miScript II RT kit (Qiagen, UK). qPCR was performed on a RotorGene™
6000 (Corbett Research) instrument in a 20 µL reaction mixture; qPCR conditions were:
95 ◦C for 30 s, 55 ◦C for 30 s and 72 ◦C for 30 s (40 cycles) using a hot start step of 95 ◦C for
15 s. Specific primers for miR-15a, -34a, -125b, -199 and -206 (Table S1) were used for the
qPCR utilising RNU6 as the reference gene [51,52]. The results were analysed using the
modified delta CT method [53].
2.7. Bioinformatic Pathway Analysis of DE miRs and miR:Target Prediction
Potential biological connections of all DE miRs were identified using Ingenuity Path-
way Analysis (IPA) (IPA, Qiagen Redwood City, CA, USA) “Core Analysis”. Putative
miR-target gene prediction was performed by uploading DE miR data into the MicroRNA
Target Filter module within IPA. This module combines experimentally validated databases,
peer-reviewed publications and target gene predictions using TargetScan [54] to identify
miR–mRNA interactions and creates biological networks describing functional associations.
For each core analysis, “diseases and bio-functions” were queried. In addition, to predict
gene targets of the selected miRs, the miRWalk on-line tool [55] was utilised by searching
through four databases: miRWalk, TargetScan, miRDB [56] and MiRTarBase [57]. Cytoscape
v3.7.2 [58] software was used to build the interaction networks between predicted targets
and selected miRs as well as to determine the biological roles of the target mRNAs utilising
Gene Ontology (GO) terms of biological process and molecular functions using the ClueGO
plug-in [59]. KEGG pathway analysis [60] was performed to determine the implication of
the predicted gene targets in biological pathways. p < 0.05 was considered to indicate a
statistically significant result.
2.8. Statistical Analysis
All data were analysed with GraphPad Prism 6 software and expressed as the mean ± SD.
Data sets were tested for Gaussian distribution with the D’Agostino–Pearson normality
test. Comparisons between the NN and NL groups were performed by unpaired Student’s
t-test or Mann–Whitney U test. Bioinformatic analyses statistics were performed with
built-in packages in IPA and Cytoscape. The p values in GO analysis were calculated with
Fisher’s Exact test corrected with Bonferroni post hoc test in Cytoscape. In all cases, p
values less than 0.05 were considered statistically significant.
3. Results
3.1. Skeletal Muscle Phenotypic Characterisation of Male Offspring
Male offspring were collected at weaning (21d) and the size and total body weight
were compared using the NN group as control (NN vs. NL and NN vs. LN). Our data
indicate that mice born from dams maintained on a normal protein diet but fed postnatally
by a foster dam maintained on a low diet (NL) showed significant reductions in body
size (Figure 1B) and total body weight (Figure 1C) at 21 days compared to NN male mice.
On the contrary, neonates born from dams on a low protein diet but were fed by dams on
normal protein diet during lactation (LN) appeared to have equal mean size and total body
weight to the NN group at weaning, as shown in Figure 1B,C. It is important to note that the
total body weight of P0 (day of birth) neonates born from dams on low protein diet (L) was
significantly lower than pups born from dams on normal protein diet (N) (Figure S1A,B).
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TA muscle weight index (expressing the net TA weight per total body weight of each
pup) for NL offspring was lower compared to NN offspring, demonstrating a profound
effect of maternal low protein consumption during lactation which was not observed in
muscles from LN males (Figure 1D). To test if muscle size was associated with muscle fibre
size, we compared the MFD in WGA stained cryosections from fibres in the midshaft of
the TA muscle. We found that the MFD of TA muscle fibres from the NL and LN groups
was significantly lower than the NN group (Figure 1E,F).
3.2. Differential Expression Analysis of miRs in TA Skeletal Muscle
Small RNA-seq was performed using total RNA isolated from TA muscles of male
offspring at weaning. All RNA samples (500 ng) were of high purity and integrity with
RNA Integrity Number (RIN) >7 as assessed on the Agilent 2100 Bioanalyzer system
(Agilent Technologies Ltd., UK). An average of 14.18 million total reads for NN, 14.72
million for NL and 14.05 million for LN group was generated, of which 13.28%, 3.65% and
13.96% were mature miRs with mapped reads of 2.05 million, 0.51 million and 1.99 million,
respectively. Normalised reads were used to estimate small RNA transcript expression
of all samples, aiming to identify the most abundant sncRNAs. In total, 796 mature miRs
were detected (Figure 2A). Only miRs with at least 10 raw reads in ≥60% of the samples
in each group (≥3 samples/group) were considered measurable, and, after filtering with
FDR ≤ 0.05 and |log2FC| > 1 (Fold Change), 179 miRs were extracted (Figure 2B). The DE
of common miRs among the three groups, 145 in total, was statistically significant when
NN and NL groups were compared, while no differences in miR expression levels were
found between NN and LN groups. The only exception was miR-122 expression, which
was slightly increased in LN group in comparison with NN (p = 0.046, Table S2).
Figure 2. Differential expression of miRs. Small RNA-seq data analysis (n = 5/group) showed differential expression
(DE) of numerous miRs, illustrated by Volcano plot (A). After filtering with FDR ≤ 0.05 and |log2FC| ≥ 1, there were
179 remaining DE miRs, where 145 were common among NN, NL and LN groups (B). Application of additional and
stricter filters, FDR ≤ 0.001 and |log2FC| ≥ 1.3, narrowed the number of common DE miRs to 92 (see Table S2); PCA
analysis indicated a profound difference between NN and NL groups (C), whilst NN and LN were mapped together. These
differences were also reflected in expression heatmap of these 92 miRs (D). The colour of each entry is determined by the
number of reads, ranging from red (positive values) to blue (negative values).
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To reduce the high number of DE mature miRs in order to have a range of the most
significant common miRs with the highest potency and a possible biological role, we
applied an additional stricter filter of FDR < 0.001 and |log2FC| > 1.3 (>2.5-fold change),
which resulted in 92 miRs (Table S2). A PCA of NN, NL and LN samples using the DE
of these 92 miRs indicated a significant difference of the NL group against the NN/LN
groups (Figure 2C). The samples of the latter groups were overlapped in the PCA plot,
indicating similarity in miR expression (Figure 2C). Finally, a heatmap revealed a clear
difference in the distribution of these 92 common miRs between the NN/LN and NL
groups of male mice (Figure 2D). Notably, two groups of samples were distinguishable:
the DE of miRs from TA muscles of NL samples were assembled in one cluster, while NN
and LN samples were presented as a combined cluster, indicating similar miR expression
levels (Figure 2D).
3.3. Ingenuity Pathway Analysis for All DE miRs
To explore the potential biological associations of the 92 DE miRs in TA skeletal
muscles from NL versus NN/LN male offspring, we undertook an IPA “Core Analy-
sis”. Networks were generated based on information from Ingenuity Pathway Knowl-
edge Database. Significant cellular functions determined by the DE miRs and predicted
gene targets included “morphology of muscle cells” (p = 0.017) and “differentiation
of muscle cells” (p = 0.008). The most interesting diseases associated with the con-
structed networks were “disarray of muscle cells” (p = 0.022) and “dystrophy of muscle”
(p = 1.11 × 10−6) (Figure 3A). The top scoring network identified was “Organismal Injury
and Abnormalities”, with p value ranging between 4.87 × 10−2 and 7.41 × 10−6 and in-
volving 62 DE miRs. Finally, IPA revealed two statistically significant GOs associated with
the DE miRs, namely “apoptosis of muscle cells” (p = 5.58 × 10−8) and “proliferation of
muscle cells” (p = 1.36 × 10−10) (Figure 3B), as well as statistically significant GOs asso-
ciated with predicted gene targets, e.g., “muscular hypertrophy” (p = 8.51 × 10−8) and
“muscle contraction” (p = 1.5 × 10−6) (Figure 3C). A full list of statistically significant GOs
associated with muscle is provided in Table S3.
3.4. Selection and Validation of miRs from Small RNA-Seq
The next step was to select miRs which demonstrated a strong difference, in terms of
both fold change DE and FDR, and among the NN, LN and NL groups of male mice which
could have an impact of skeletal muscle development. We focused on four miRs: miR-15a,
-34a, -122 and -199a. These specific miRs were selected based on our current work, the level
of DE and following a literature search of the DE genes.
Among the 92 mature miRs with statistically significant DE, 42 were found with lower
expression levels in NN/LN as compared to the NL group, including miR-122, while 50
were upregulated in NN/LN, including miR-15a, -34a and -199a (Figure 4A). Next, we
tested if the selected miRs (miR-122, miR-15a, miR-34a and miR-199a) in combination with
established and well-studied muscle-specific myomiRs [26], such as miR-1, -133a, -133b,
-206, -208b, -486 and -499, known regulators of muscle cell proliferation and differentiation,
can form a group of miRs able to profoundly distinguish the two groups of mice based on
their expression levels in TA skeletal muscle. Indeed, a miR expression levels-generated
heatmap, including these miRs, showed a clear DE of this group of miRs, highlighting the
significant phenotypic difference in skeletal muscles affected by maternal protein restriction
during lactation in NL males (Figure 4B). Finally, qPCR analysis was used to validate the
miR-seq data. We found that miR-122 was expressed at higher levels in NL (Figure 4C), but
not LN, a finding that contradicts the sequence data. miRs-15a, -199a and -34a expression
levels were significantly lower in the NL mice, as shown in Figure 4D–F, respectively. These
results are in agreement with miR-seq, while miR-206 expression levels were higher in NN
than in NL and LN, which contradicts the sequence data (Figure 4G). In addition, miR-34a
expression levels were found lower by qPCR in LN as compared to NN, a result which also
opposes the miR-seq data (Figure 4B,F).
Cells 2021, 10, 1166 8 of 20
Figure 3. Bioinformatic analyses of differentially expressed miRs. Ingenuity Pathway Analysis representation of functions
using DE miRs between NN/LN and NL male groups. Differentiation, morphology and disarray of muscle cells were
identified by IPA as the predominant cellular functions and dystrophy of muscle as the most relevant disease which
were correlated with the 92 differentially expressed miRs (A). Top GO terms identified in miR IPA core analysis were
apoptosis and cell proliferation which relate to specific miRs (B). Muscle hypertrophy and contraction were the top GO
terms associated with predicted gene targets of DE miRs (C). Figures are graphical representations of miRs identified in
our data in their respective networks. Red nodes correspond to upregulated gene expression in NN/LN, and green nodes
downregulation. Intensity of colour is related to higher fold-change. Legends to the main features in the networks are
shown. The function colour is dependent on whether it is predicted to be activated or inhibited.
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Figure 4. Validation of selected differentially expressed miRs by qPCR. Among the 92 miRs with DE between NN/LN and
NL as determined by small RNA-seq, miR-122 expression was higher in NL, whereas miR-15a, -34a and -199a were found
upregulated in NN and LN (A). The combination of these four miRs with known myomiRs revealed an interactive set of
skeletal muscle-associated miRs in which the degree of DE between NN/LN and NL is very strong, as illustrated by the
expression heatmap (B). The colour of each entry is determined by the number of reads, ranging from yellow (negative
values) to brown (positive values). To confirm the expression levels, validation by qPCR showed increased expression in NL,
but not in LN, for miR-122 (C). The results were similar between small RNA-seq and qPCR for miR-15a (D) and miR-199a
(E), while for miR-34a (F) and miR-206 (G) were different between the two detection systems. * p < 0.05, ** p < 0.01.
3.5. Selected miRs-15a, -34a, -122 and -199a Bioinformatic Pathway Analysis
Based on the observations and data described above, we performed a bioinformatic
analysis to explore the possible molecular pathways and cellular functions that the pre-
dicted target genes of our selected mature miRs could be implicated in. Using a combination
of strict parameters, i.e., seed length range 16–21 at the 3′-UTR site, binding p value of 1 and
showing only the statistically significant mRNAs which occurred in all three miR databases
(TargetScan, miRDB and MiRTarBase), we identified 70 predicted target genes in total for
the four selected miRs (Figure 5A). GO analysis using the GlueGO plug-in of the Cytoscape
software and including biological process, cellular functions and KEGG pathways revealed
an interactive molecular network, as shown in Figure 5B. The six GO terms with the lower p
values after Bonferroni corrections were: “cerebellum morphogenesis” (p = 0.0017), “embry-
onic pattern specification” (p = 0.0015), “regulation of striated muscle cell apoptotic process”
(p = 4.2 × 10−4), “embryonic cranial skeleton morphogenesis” (p = 2.21 × 10−4), “positive
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regulation of cellular response to insulin stimulus” (p = 5.13 × 10−5) and “regulation of
histone methylation” (p = 4.41 × 10−5) (Figure 5C).
Figure 5. Bioinformatic network of selected miRs predicted gene targets. Target analysis of miR-15a, -34a, -199a and -122 by
Cytoscape showed numerous (70) predicted gene targets (A). KEGG pathway analysis of the 70 predicted genes indicated
that they could interact with each other forming a molecular network that can regulate significant as well as diverse
developmental processes. Small circles represent a range of p value of 1.5–1.7 × 10−3, moderate circles 2.2–4.2 × 10−5
and large circles 4.4–5.1 × 10−5 after Bonferroni correction (B). The most significant GO showing statistical significance
were cerebellum morphogenesis, embryonic pattern specification, regulation of striated muscle cell apoptotic process,
embryonic cranial skeleton morphogenesis, positive regulation of cellular response to insulin stimulus and regulation of
histone methylation (C).
Furthermore, to assess if our selected miRs interact with muscle-specific myomiRs,
we used an in silico approach via Cytoscape, which revealed that this set of miRs appear
to share some common gene targets forming an interrelated network (Figure S2A). GO
analysis showed that this combination of miRs (selected plus myomiRs) were involved in
important developmental stages of the musculoskeletal system including motor neuron
axon guidance and negative regulation of muscle tissue development (Figure S2B,C).
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3.6. Analysis of DE snoRNAs and snRNAs in TA Skeletal Muscle
We further analysed the small RNA-seq datasets to identify the DE snoRNA and snR-
NAs from TA skeletal muscles. Averages of 14.18 million total reads for NN, 14.72 million
for NL and 14.05 million for LN group were generated, of which 12.77%, 14.95% and
10.88% were snoRNAs and snRNAs with mapped reads of 1.80 million, 2.22 million and
1.51 million, respectively. We detected 514 snoRNA and snRNAs in total, of which 95 were
considered statistically significant, having FDR ≤ 0.05 and |log2FC| > 1.3 (Figure 6A).
It is worth noticing that, of these 343 sncRNAs, 2 were identified as snRNAs (RNU3a
and RNU73b), 39 H/ACA box snoRNAs (SNORA), 80 C/D box snoRNAs (SNORDs),
2 small Cajal body-specific RNAs (scaRNAs) and 220 uncharacterised (Figure 5B). After
FDR and log2FC filter application, we used 2 snRNAs, 11 SNORAs, 26 SNORDs and 56
uncharacterised sncRNAs (Figure 6B and Table S4). The analysis of normalised counts
showed that Rnu3a was highly expressed in the TA muscles from NL group in comparison
with either NN or LN. On the contrary, Rnu73a expression was significantly increased in
NN and LN mice (Figure 6C). PCA analysis using DE SNORAs and SNORDs showed that
NL samples were clustered tightly while NN and LN samples were grouped (Figure 6D).
The heatmap representing DE revealed a clear difference in the distribution of SNORAs
and SNORDs between the NN/LN and NL groups of male mice (Figure 6E).
Figure 6. Bioinformatic analyses of differentially expressed sn/snoRNAs. Small RNA-seq data analysis revealed DE of multiple
snRNAs and snoRNAs, as shown in the Volcano plot (A). Filters application of FDR ≤ 0.05 and |log2FC| ≥ 1.3 indicated the
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residual 95 DE sncRNAs, of which 56 were uncharacterised (B). The expression levels of snRNAs showed statistically
significant upregulation of RNU3a and downregulation of RNU73b in NL group in comparison with NN and LN groups
(C). PCA analysis demonstrated a profound difference between NN and NL groups (D), whilst NN and LN were clustered
together. DE expression levels of SNORAs and SNORDs were plotted as heatmap suggesting distinct clusters of NN/LN
and NL samples (E). The colour of each entry is determined by the number of reads, ranging from blue (negative values) to
red (positive values). ** p < 0.01 as compared to NN, && p < 0.01 as compared to LN; ns, not significant.
4. Discussion
In this study, we report that maternal protein undernutrition during lactation (NL)
causes a significant decrease in body mass, skeletal muscle weight and muscle fibre size
in male offspring at weaning. This phenotype was accompanied by a very strong DE of
numerous miRs as well as snRNAs and snoRNAs between NN and NL groups of mice. We
also found that, among the plethora of altered miRs, there are four previously unreported
DE miRs which strongly correlate with muscle-specific myomiRs and in silico bioinformatic
analyses, implicating them in important developmental processes of the musculoskeletal
system. Additionally, we demonstrated that mice born from dams fed a low protein diet
during gestation but exposed to normal amounts of protein during lactation (LN) have a
similar growth to the NN offspring with no apparent differences in body size, body weight
or muscle weight at weaning. However, despite the lack of difference in weight, the TA
myofibre size in these mice was reduced, which is similar to the reduction observed in the
TA myofibres of the NL offspring.
There is growing evidence that the early-life nutritional environment, both in utero
and in the early postnatal period, can have persistent long-lasting effects on later life health.
Based on the developmental programming concept, this intergenerational effect can lead
to high risk of obesity, type 2 diabetes and cardiovascular diseases [1,61]. Skeletal muscle
is characterised by plasticity and is highly adaptive to nutritional changes by altering
size, metabolic rates and functional properties. It is also affected in response to maternal
nutritional imbalance by changes in offspring phenotype [10,62–64]. During foetal devel-
opment, undernutrition can determine muscle fibre formation and growth in the offspring
by suppression of muscle development associated gene expression [65]. Pregnancy and
lactation are considered as critical periods, and it is evident that nutrient restriction before
weaning may cause permanent changes in skeletal muscle [66]. Consistently, our results
demonstrate that maternal low protein intake during lactation results in lower total body
and skeletal muscle weight in NL male offspring. The result that pups at birth were found
different in size and weight (depending on maternal protein diet during gestation) is in
accordance with previous reports [67]. It appears that maternal diet during lactation can
modify neonatal growth, since the LN group showed accelerated catch up growth and
reached the same size and weight with the NN group at weaning, but not muscle fibre
size. On the other hand, although P0 pups from mothers on normal protein diet are bigger,
maternal low protein diet during lactation constrains their growth, resulting in smaller
size of both total body and muscle fibres. During postnatal developmental stages, skeletal
muscle growth is attained by muscle fibre size increase, and not muscle fibre number,
mainly by satellite cells proliferation and myoblasts fusion [68], and muscle-specific net
protein hypertrophic increase until 3 weeks of age [69]. Our results reveal that maternal low
protein intake during pregnancy and/or lactation results in decreased size of myofibres,
as assessed by fibre size measurements, consistent with other studies in rat [63]. This
suggests that gestational as well as lactational protein feeding determines the skeletal
muscle fibre size. This is crucial, since the myofibre number is still growing shortly after
birth in rodents [70–72]. However, most studies have mainly focused on maternal high-fat
diet [73] and cafeteria diets [74,75], but little is known about the mechanisms of low protein
diet and how it affects muscle development in the offspring.
Although myogenesis is extensively studied, the focus has been limited to transcrip-
tion factors and gene regulation. During the last decade, myomiRs have triggered the
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attention of many studies and next generation sequencing analyses have confirmed that
myomiRs are abundant in muscle tissue [30]. MyomiRs are expressed in both cardiac and
skeletal muscle with the exception of miR-206 [27], which is skeletal muscle-specific. Other
studies have reported that some myomiRs are also expressed in other tissues at low levels,
but it is accepted that their main roles are still in muscle [25]. For example, miR-486 is often
referred to as “muscle-enriched” rather than “muscle-specific” because is expressed in other
tissues as well [29]. In our study, we aimed to describe the miR signature that maternal
low protein intake establishes in the skeletal muscle of male offspring. The skeletal muscle
phenotypic differences between NN and NL groups was complemented with a profound
change in miR signature, resulting in a clear distinguishable grouping of mice in PCA
analysis and expression heatmaps. As expected, among the 92 DE miR that we found, after
applying very strict statistical limits to ensure high accuracy of our results, myomiRs were
included. Their expression levels during skeletal muscle development have been reported
previously. miR-1 and miR-133a, for example, are upregulated by MyoD and MyoG during
both human and mouse skeletal muscle differentiation in vitro [76,77] and in vivo [78,79]
and also support myogenic differentiation [80,81]. Furthermore, miR-1/206/133 control
embryonic myogenesis through regulation of BAF chromatin remodelling complexes [82].
Our findings are in agreement with these expression levels, i.e., miR-1 and -133a were
significantly downregulated in the NL group compared with the NN group at weaning.
It is also known that miR-1 and -206 suppress Pax7 expression and act as regulators of
satellite cell proliferation and differentiation [81]. Postnatal muscle hypertrophy may also
be regulated by satellite cell number per fibre at birth and their rate of proliferation as well
as protein deposition (i.e., protein synthesis and degradation) [83]. Therefore, our future
studies will focus on satellite cells which will be assessed in histological sections.
miR-206 was downregulated in NL mice and in LN mice too and validated by qPCR. It
has been shown that miR-206 is highly expressed in newly formed muscle fibres, indicating
that miR-206 may be involved in muscle regeneration and maturation [84]. Moreover,
miR-206 directly targets Pax3, and inhibition with antagomirs results in delayed myo-
genic differentiation [85], but the miR-206 family is not essential for in vitro myogenesis,
although it modulates the differentiation of skeletal myoblasts [86]. These results clearly
demonstrate that the animal model used in the present study is valid and produces reliable
sequencing data in accordance with the phenotypic outcome, since muscle size and miR
expression are consistent with previous literature. Therefore, we proceeded to select and
validate novel miRs that may have key functions in the nutrition-dependent developmental
programming of skeletal muscle. It is reported that miR-15a has the highest expression
level in skeletal muscle in comparison with other tissues [87] and is upregulated during
human skeletal myoblast differentiation [88]. In addition, miR-34a targets thioredoxin
reductase 2 (TXNRD2), which plays an important role in redox homeostasis of skeletal
muscle [89] and is also involved in neuronal development [90]. Circulating miR-122 can
enter muscle and adipose tissues in mice and reduce mRNA levels of genes involved in
triglyceride synthesis and, thus, regulate energy balance [91]. Finally, miR-199a-3p expres-
sion is highly expressed in skeletal muscle and controls genes of the IGF1/Akt/mTOR
signalling pathway to regulate C2C12 myoblasts differentiation [92].
It has also been previously reported that foetal exposure to maternal diabetes is asso-
ciated with increased skeletal muscle expression of miR-15a, and that this may contribute
to development of metabolic disease in later life [93]. Furthermore, miR-15a expression is
elevated in powerlifters as compared to normal human controls [94] showing a positive
correlation with increased muscle mass and strength. miR-34a was also downregulated in
NL mice and LN mice, as shown by qPCR. miR-34a has been shown to induce senescence
of endothelial progenitor cells by inhibiting SIRT1, which results in increased levels of
acetylated FOXO1 [95] and, thus, inhibits skeletal muscle development. Other studies
suggest that Sirt1 antisense (AS) long non-coding RNA (lncRNA) interacts with its mRNA
to inhibit muscle formation by attenuating function of miR-34a [96]. Additionally, several
reports describe that miR-34a plays important roles in neuronal development [89]. Specifi-
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cally, miR-34a has been shown to regulate spinal morphology and neurite outgrowth and is
associated with both morphological and electrophysiological changes in mouse models [97].
Ectopic expression of miR-34a has also been shown to modulate neural differentiation by
increasing the percentage of post-mitotic neurons and neurite elongation of mouse neural
stem cells, whereas antagomirs of miR-34a had the opposite effect, suggesting that miR-34a
is required for proper neuronal differentiation [98]. Differences in the timing of changes in
muscle innervation during development between human and in small mammals have been
reported, thus in human the transition from poly- to mono-neuronal muscle innervation
takes place between the 16 and 25 weeks of gestation, whereas in rodents these changes
occur relatively later in the first two weeks after birth [99]. It is therefore possible that the
reduction in miR-34a evident in both NL and LN groups is associated with dysregulation of
muscle fibre innervation due to inadequate intake of protein during gestation or lactation
and our future studies will focus on examining any specific changes occurring in muscle
innervation in these mice phenotypically.
Although miR-122 is considered as a striated muscle-specific miR [25], its function
has not been extensively explored. However, it is known to exhibit an inhibitory role of
in the TGFβ/Smad signalling pathway in skeletal muscle fibrosis after contusion [100].
Finally, miR-199a regulates myogenic differentiation by acting downstream of Srf, which
targets multiple factors within the Wnt signalling pathway [79]. Based on this literature,
we selected miRs-15a, -34a, -122 and -199a and examined the DE of miR-seq by qPCR.
Our bioinformatic approaches revealed that our validated miRs are predicted to target a
variety of genes that regulate different developmental processes including striated muscle
cell apoptosis and histone methylation, which is associated with epigenetic regulation of
embryonic myogenesis [101]. Importantly, these miRs share a variety of common predicted
gene targets that are implicated in skeletal muscle physiology with myomiRs. We, therefore,
conclude that the four selected miRs can serve as a complement of known myomiRs and
form a promising set to monitor skeletal muscle development, but further studies need
to confirm this idea. Considering that tissue-specific miR expression can be affected by
the nutritional status and, in this case, the maternal low protein consumption particularly
during lactation, we can conclude that the DE of these miRs might be the cause of reduced
myofibre size in NL mice. The present study also highlights the importance of a maternal
balanced diet especially during lactation as this has a direct impact on offspring health. A
limitation of our work is that we have not examined the role of our selected miRs in vitro,
e.g., by using C2C12 cells to evaluate fusion and myofibre formation, or in vivo by direct
injections of miRs or antagomiRs and assessment of skeletal muscle integrity throughout
life course. However, these approaches are beyond the scope of our present study and we
intend to include them in our future work.
The increase in skeletal muscle mass after birth occurs primarily through muscle
fibre hypertrophy given that fibre number is established during early postnatal develop-
ment [102]. The amount of protein synthesised by a cell is dependent on translational
capacity and efficiency. Ribosome biogenesis is as an important regulator of skeletal muscle
growth and maintenance by changing the cellular translational capacity. There is a role
for ribosome biogenesis in skeletal muscle growth during postnatal development [103].
In mammals, the ribosome is assembled from ribosomal RNAs (rRNAs), together with
at least 80 different protein subunits [31]. Within the ribosome, 18S rRNA guides the
decoding of the mRNA, whereas 28S rRNA forms the core of the peptidyltransferase centre
that polymerises the amino acid sequence encoded by the mRNA into functional proteins.
Maturation post-transcriptionally of rRNAs is part of the biosynthesis of ribosomes [104].
47S rRNA ribonucleolytic processing into mature 18S, 5.8S and 28S rRNAs is rate-limiting
for ribosome biogenesis [105]. We identified an increase in U3 in NL compared to NN.
Whilst a network of snoRNAs is involved in key ribosome biogenesis processes [106], U3 is
a factor in the generation of 18S rRNA [106]. This snoRNA is a highly abundant and evolu-
tionarily conserved box C/D-class snoRNA, guiding the endoribonucleolytic processing
of the 5′ external transcribed spacer (ETS) of the 47S pre-rRNA by base complementarity-
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guided pre-rRNA substrate recognition [107]. It has a key role in the maturation of 18S
rRNA [108,109]. In cartilage, we demonstrated the global impact of reduced U3 expression
on protein translational processes and inflammatory pathways and found that altering
U3 expression has a direct effect on rRNA expression and translational capacity of chon-
drocytes. We showed that the extracellular environment is capable of controlling cellular
U3 levels, thereby tuning the cell’s capacity to generate mature rRNA species [110]. The
increase in U3 in NL may be a compensatory method to protein restriction.
Although miRs have been extensively studied, very limited evidence refers to the role
of non-miR sncRNAs in muscle development [111]. Several SNORDs, such as SNORD-116,
-48, -84, -95 and -97, showed DE in skeletal muscle of Amyotrophic Lateral Sclerosis (ALS)
patients as compared to healthy controls [112]. RNA-seq analysis using serum and muscle
samples of Duchenne Muscular Dystrophy (DMD) patients also revealed altered snoRNA
and snRNA levels, suggesting their use as potential biomarkers for DMD [113]. Here, we
report that low protein intake during lactation in NL male mice results in DE of multiple
snoRNAs of both C/D and H/ACA box subtypes with canonical roles, for the first time in
the literature. Two snoRNAs (SNORD33 and SNORD35) were reduced in NL. Whilst these
snoRNAs have canonical roles [114], they additionally have non-canonical roles as regula-
tors of metabolic and oxidative stress pathways in mammalian cells as they were induced
in vivo in response the generalised oxidative stress [115]. Loss of their host gene Rpl13a
altered mitochondrial metabolism and lowered reactive oxygen species (ROS) produc-
tion, but the snoRNAs are themselves regulated by reactive oxygen species and oxidative
stress, with dynamic accumulation of snoRNAs in the cytoplasm in response to oxidative
stress [116]. In human knee cartilage, we identified changes in these “oxi-snoRNAs” in
ageing and osteoarthritis, and this was a cross species effect. Our in vitro experiments
demonstrated that they respond to their environment and oxidative stress stimuli and
using physiological levels of ROS generated using fibronectin fragments increased the
expression these snoRNAs [117]. In skeletal muscle, suboptimal maternal nutrition fol-
lowed by accelerated postnatal growth has been shown to induce an accelerated ageing
phenotype and oxidative stress in adult offspring male rats. Specifically, Tarry-Adkins et al.
demonstrated that rats born to dams fed on low protein chow but suckled postnatally by a
dam maintained on a normal diet until weaning and maintained on a normal diet until
12 months of age have accelerated telomere shortening and increased DNA damage, which
was associated with a strong oxidative stress phenotype, a compensatory increased antioxi-
dant defence enzyme activity and inflammation [118]. The authors also demonstrated that
mitochondrial dysfunction was evident in the muscle of the offspring by a reduction in
citrate synthase activity (a marker of intact mitochondria) and increased Complex I, linked
Complex II III and Complex IV electron transport chain (ETC) activity, suggesting that
muscle mitochondria might have to compensate for fewer mitochondria by increasing the
activity of ETC complexes to generate sufficient ATP, which in turn produces more ROS.
Although we did not examine these changes directly in this study, we speculate that these
ROS-related mechanistic changes occur as a consequence of suboptimal in utero and early
environments and are affected directly by oxi-miRs and/or oxi-snoRNAs, and this in turn
leads to the development of ROS induced age-related diseases including sarcopenia [118].
5. Conclusions
We here report that small RNA-seq reveals numerous sncRNAs which are correlated
with reduced skeletal muscle size of 21d male offspring that were lactated from mouse
dams on low protein diet. We further describe four differentially expressed miRs, miRs-15a,
-34a, -122 and -199a, that may be implicated in this process. These selected miRs could be
combined with established myomiRs composing an interactive biomolecular network that
may regulate this effect, as the bioinformatic approach revealed. Finally, to our knowledge,
this is the first study exploring the role of snoRNAs in muscle development under restricted
diet conditions. Although we do not provide a mechanistic explanation or a functional
outcome of these alterations, our study suggests novel sncRNA signatures and identify
Cells 2021, 10, 1166 16 of 20
potential candidates for innovative directions in muscle development. Future studies will
facilitate uncovering the detailed molecular mechanisms.
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